[go: up one dir, main page]

ATE256745T1 - Therapeutischer- und präventivimpfstoff gegen hiv - Google Patents

Therapeutischer- und präventivimpfstoff gegen hiv

Info

Publication number
ATE256745T1
ATE256745T1 AT92907420T AT92907420T ATE256745T1 AT E256745 T1 ATE256745 T1 AT E256745T1 AT 92907420 T AT92907420 T AT 92907420T AT 92907420 T AT92907420 T AT 92907420T AT E256745 T1 ATE256745 T1 AT E256745T1
Authority
AT
Austria
Prior art keywords
hiv
conjugates
therapeutic
vaccine against
against hiv
Prior art date
Application number
AT92907420T
Other languages
English (en)
Inventor
Arye Rubinstein
Barry R Bloom
Yair Devash
Stanley Cryz
Original Assignee
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Einstein Coll Med filed Critical Einstein Coll Med
Application granted granted Critical
Publication of ATE256745T1 publication Critical patent/ATE256745T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT92907420T 1991-04-02 1992-04-02 Therapeutischer- und präventivimpfstoff gegen hiv ATE256745T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68162491A 1991-04-02 1991-04-02
US83778192A 1992-02-14 1992-02-14
PCT/EP1992/000735 WO1992017590A1 (en) 1991-04-02 1992-04-02 Therapeutic and preventive vaccines for hiv

Publications (1)

Publication Number Publication Date
ATE256745T1 true ATE256745T1 (de) 2004-01-15

Family

ID=27102688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907420T ATE256745T1 (de) 1991-04-02 1992-04-02 Therapeutischer- und präventivimpfstoff gegen hiv

Country Status (7)

Country Link
EP (1) EP0536352B1 (de)
JP (1) JPH05508165A (de)
AT (1) ATE256745T1 (de)
AU (1) AU1532392A (de)
CA (1) CA2083949A1 (de)
DE (1) DE69233271T2 (de)
WO (1) WO1992017590A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
IL110929A0 (en) * 1993-09-13 1994-11-28 Armel Sa Multiple branch peptide constructions and pharmaceutical compositions containing them
GB9318901D0 (en) * 1993-09-13 1993-10-27 Centre Nat Rech Scient Multiple branch peptide construction
US6838553B1 (en) * 1999-10-05 2005-01-04 Academia Sinica Peptide repeat immunogens
US8915965B2 (en) 2009-05-07 2014-12-23 Depuy (Ireland) Anterior stabilized knee implant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436634A1 (de) * 1988-10-03 1991-07-17 Repligen Corporation Hiv-proteine und peptide und deren verwendung zur diagnose, prophylaxe und therapie von aids
IL94558A0 (en) * 1989-06-06 1991-03-10 Merck & Co Inc Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV

Also Published As

Publication number Publication date
JPH05508165A (ja) 1993-11-18
DE69233271T2 (de) 2004-09-09
AU1532392A (en) 1992-11-02
CA2083949A1 (en) 1992-10-03
EP0536352A1 (de) 1993-04-14
EP0536352B1 (de) 2003-12-17
WO1992017590A1 (en) 1992-10-15
DE69233271D1 (de) 2004-01-29

Similar Documents

Publication Publication Date Title
RU2221045C2 (ru) ОМР26 АНТИГЕН Haemophilus influenzae, КОДИРУЮЩАЯ ЕГО НК И ЕГО ИСПОЛЬЗОВАНИЕ
AP2002002592A0 (en) Vaccine for the prophylactic or therapeutic immunization against HIV.
WO2002096937A3 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
WO2001039796A3 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
WO2002020554A3 (en) Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
IE903899A1 (en) Vaccine composition with non-immunosuppressive T-cell¹epitope component
SE9500418D0 (sv) Novel attenuated pseudomonas aeruginosa strains
OA09802A (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus.
Zhou et al. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice
EP0491628A3 (de) Lipopeptide, T-cytotoxische Lymphocyte aktivierend, und deren Verwendung als Vakzine
ATE256745T1 (de) Therapeutischer- und präventivimpfstoff gegen hiv
Que et al. Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites
IE904412A1 (en) Malaria vaccine
DE69626642D1 (de) Cetp zur erhöhung des hdl-cholesterol-gehalts
WO2005058968A1 (en) A method to make a peptide-carrier conjugate with a high immunogenicity
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
WO2003029285A3 (en) Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
CN117440825A (zh) 基于SARS-CoV-2病毒的受体结合结构域的疫苗组合物在保护性免疫的发展中的用途
DK1146889T3 (da) Identifikation af specifikke differentielt udtrykte mycobakterielle antigener og medicinsk anvendelse af Mycobakteriumproteinerne Rv0068 og Rv3407
ATE454394T1 (de) Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen
KR890000106A (ko) 원생성 기생충 예방용 백신
Kaushik et al. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid
JPH08198774A (ja) Ｄｎａワクチン
WO2003073984A3 (en) Tat as an immunogen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties